We value your privacy

We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.

HomeHormone TherapyNon-Hormonal Menopause TreatmentColorado
Mountain West · Telehealth Available

Non-Hormonal Menopause Care for Women in Colorado

Written by the Kindr Health Editorial & Clinical TeamMedically reviewed by Kindr Health Clinical Team NPI 1609792902Published Last reviewed

For women who cannot or prefer not to use hormone therapy, evidence-based non-hormonal treatments including paroxetine and desvenlafaxine are available — targeting vasomotor symptoms and mood disruption without estrogen. Available to women across Colorado's high-altitude semi-arid climate — entirely online.

Start Your Free Intake →

Licensed in Colorado · FDA-registered pharmacy · Reviewed within 24 hours · Ships free

Is Non-Hormonal Menopause Treatment right for women in Colorado?

Connect with a kindr-licensed provider who can evaluate whether Non-Hormonal Menopause Treatment is appropriate for your health history and symptoms — from anywhere in Colorado.

  • Hot flashes and night sweats
  • Mood changes and anxiety
  • Sleep disruption
  • Cannot or prefer not to use estrogen
  • History of hormone-sensitive conditions

Non-Hormonal Menopause Treatment in Colorado: what is specific to your state

Colorado care density follows the Front Range from Fort Collins to Colorado Springs, leaving the Western Slope and San Luis Valley with long mountain drives to the nearest specialist. That is the gap non-hormonal menopause treatment by telehealth closes for Colorado: roughly ~750k of women here are in the menopausal transition, and most of them do not live within easy reach of Denver or Denver.

Every clinician who treats you holds a full, active Colorado license in good standing with the Colorado Medical Board, and prescribes only within the standards that board sets — a documented history, a real evaluation, and a written record for each prescription. Any pharmacy dispensing to a Colorado address is licensed with the Colorado Board of Pharmacy. We do not bill Health First Colorado or commercial Colorado plans; care is a flat monthly subscription, and we will provide an itemised receipt if you want to submit it yourself.

Colorado sits in Mountain West with a high-altitude semi-arid climate, and that shows up in how symptoms present here. High altitude and dry air worsen vaginal dryness and skin symptoms; topical estradiol and barrier moisturizers help.

Licensing board
Colorado Medical Board
Pharmacy regulator
Colorado Board of Pharmacy
State Medicaid program
Health First Colorado
Region
Mountain West
Capital
Denver
Largest metros served
Denver, Colorado Springs, Aurora

Moved recently, or split your year across state lines? Care continues wherever our clinicians are licensed. Nearby coverage: Utah · Wyoming · New Mexico · Kansas · Nebraska

What is non-hormonal menopause treatment?

Non-hormonal menopause treatments are prescription medications that reduce vasomotor symptoms (hot flashes, night sweats) and, in many cases, associated mood and sleep disruption — without altering estrogen or progesterone levels. The category includes select SSRIs and SNRIs (paroxetine, desvenlafaxine, escitalopram, venlafaxine), gabapentin, and the newer neurokinin-3 receptor antagonist fezolinetant.

These medications are the standard of care for women with a history of hormone-sensitive cancer, personal or strong family history of venous thromboembolism, or other conditions where estrogen is contraindicated — and for women who simply prefer a non-hormonal approach.

How non-hormonal menopause treatment works

SSRIs and SNRIs modulate serotonin and norepinephrine signaling in the hypothalamic thermoregulatory center, reducing the exaggerated heat-loss response that produces hot flashes. Gabapentin acts through calcium channel modulation and is especially useful for nighttime symptoms. Fezolinetant blocks neurokinin-3 receptors on hypothalamic KNDy neurons, directly reducing the neurologic driver of vasomotor symptoms discovered in recent decade of menopause research.

The clinical evidence

Paroxetine (7.5 mg) is the only FDA-approved non-hormonal medication specifically labeled for vasomotor symptoms of menopause, based on two randomized controlled trials showing significant reduction in hot flash frequency and severity. Fezolinetant (Veozah), FDA-approved in 2023, showed 55-65% reduction in moderate-to-severe hot flashes at 12 weeks in the SKYLIGHT trials — comparable to hormone therapy.

NAMS 2023 non-hormonal position statement identifies fezolinetant, paroxetine, desvenlafaxine, escitalopram, gabapentin, and oxybutynin as evidence-based options for vasomotor symptoms in women who cannot or choose not to use hormone therapy.

Who is a good candidate?

  • Women with a personal history of hormone-sensitive breast or endometrial cancer
  • Women with history of venous thromboembolism or elevated thrombotic risk
  • Women with hormone-related contraindications to estrogen
  • Women whose primary symptoms are mood-driven alongside vasomotor
  • Women who prefer a non-hormonal option regardless of eligibility for HRT

Contraindications

  • Concurrent tamoxifen use with paroxetine (paroxetine inhibits its activation)
  • Known hypersensitivity to the specific medication
  • Active bipolar disorder (SSRI/SNRI cautions)
  • Severe hepatic impairment (fezolinetant)
  • Combination with monoamine oxidase inhibitors

Common side effects

Most side effects are mild and settle within the first 4-8 weeks. Report anything severe or persistent to your prescriber.

  • Nausea in the first 1-2 weeks of SSRIs/SNRIs
  • Dizziness or fatigue with gabapentin
  • Sexual side effects with some SSRIs
  • Elevated liver enzymes (fezolinetant — monitored with routine labs)
  • Discontinuation symptoms if stopped abruptly

Alternatives to consider

Fezolinetant (Veozah)
Newest, non-hormonal, hormone-therapy-comparable efficacy
Cognitive behavioral therapy
Evidence-based for hot flashes and sleep
Weight loss and lifestyle
Meaningful reductions in vasomotor symptom burden
Vaginal estrogen (local only)
Compatible with most non-hormonal protocols for GSM

Sources

  1. The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society. Menopause. 2023;30(6):573-590.
  2. Depypere H et al. Fezolinetant for treatment of moderate-to-severe vasomotor symptoms: the SKYLIGHT 1 and 2 trials. Menopause. 2023.
  3. Simon JA et al. Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms. Menopause. 2013;20(10):1027-1035.
  4. Stuenkel CA et al. Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(11):3975-4011.

Medically reviewed by the kindr Clinical Team. Content reflects the 2022 NAMS Position Statement and current Endocrine Society guidelines. Last reviewed 2026.

How kindr delivers care in Colorado

Step 1

Complete your intake online from anywhere in Colorado

Step 2

A licensed Colorado provider reviews within 24 hours

Step 3

If prescribed, ships free to your door

A kindr physician reviews your health history and reasons for avoiding HRT. Non-hormonal prescription alternatives are evaluated and prescribed where clinically appropriate — shipped monthly.

What to expect

  • Weeks 1-2
    Early tolerance established; initial mild symptom reduction
  • Weeks 4-6
    Meaningful hot flash reduction (fezolinetant faster)
  • Weeks 8-12
    Full effect established; dose refinement complete
  • Months 6+
    Long-term maintenance and reassessment

In 2025, the FDA updated its guidance on hormone therapy for menopause, removing longstanding warnings that had deterred many women from effective treatment. Speak with a kindr provider about what this means for you.

Clinical standards in Colorado

Board-certified MDs and DOs licensed in Colorado
FDA-registered 503A pharmacy fulfillment
HIPAA compliant and SOC 2 certified
Telehealth permitted under state law

Colorado frequently asked questions

Ready to speak with a Colorado-licensed provider?

Connect with a board-certified kindr physician licensed to practice in Colorado. No waiting rooms. No referrals. Reviewed within 24 hours.

Start Your Free Intake →

Non-Hormonal Menopause Treatment is a prescription medication. A licensed provider must evaluate whether this treatment is right for you. kindr is not a pharmacy. Medications are prescribed by licensed independent physicians and fulfilled by FDA-registered 503A compounding pharmacies. kindr does not guarantee any specific treatment will be prescribed.